应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NTHI NeOnc Technologies Holdings
休市中 02-13 16:00:00 EST
10.24
-0.22
-2.15%
盘后
10.24
+0.00
0.00%
16:00 EST
最高
10.49
最低
10.03
成交量
4.39万
今开
10.32
昨收
10.47
日振幅
4.37%
总市值
2.32亿
流通市值
8,465万
总股本
2,269万
成交额
45.35万
换手率
0.53%
流通股本
826.64万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Neonc Technologies获Cinctive Capital Management领投1000万美元战略PIPE投资
美股速递 · 01-30
Neonc Technologies获Cinctive Capital Management领投1000万美元战略PIPE投资
NeOnc Technologies Holdings:向市场提交出售最多111,732股普通股的招股说明书
美股速递 · 2025-12-24
NeOnc Technologies Holdings:向市场提交出售最多111,732股普通股的招股说明书
NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性
美股速递 · 2025-11-12
NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性
NeOnc Technologies Holdings 达到44%的六个月无进展生存率,超越基准
美股速递 · 2025-11-12
NeOnc Technologies Holdings 达到44%的六个月无进展生存率,超越基准
Neonc Technologies任命Amir Heshmatpour为首席执行官,以推动临床和企业增长的下一个阶段
美股速递 · 2025-11-04
Neonc Technologies任命Amir Heshmatpour为首席执行官,以推动临床和企业增长的下一个阶段
NeOnc Technologies Holdings子公司Nuromena与M42旗下Iros签署主服务协议并扩充董事会
美股速递 · 2025-10-09
NeOnc Technologies Holdings子公司Nuromena与M42旗下Iros签署主服务协议并扩充董事会
NeOnc Technologies Holdings任命杜克大学Preston Robert Tisch脑肿瘤中心主任David M. Ashley博士加入科学顾问委员会
美股速递 · 2025-10-02
NeOnc Technologies Holdings任命杜克大学Preston Robert Tisch脑肿瘤中心主任David M. Ashley博士加入科学顾问委员会
NeOnc Technologies欢迎NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任Alexandra M. Miller博士加入科学顾问委员会
美股速递 · 2025-10-01
NeOnc Technologies欢迎NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任Alexandra M. Miller博士加入科学顾问委员会
NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会
美股速递 · 2025-09-29
NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会
Neonc Technologies Holdings, Inc.盘中异动 股价大涨6.13%
市场透视 · 2025-09-10
Neonc Technologies Holdings, Inc.盘中异动 股价大涨6.13%
NeOnc Technologies获得FDA批准进入Neo212二期临床试验——首创口服化学共轭化疗药物用于脑癌治疗
美股速递 · 2025-09-10
NeOnc Technologies获得FDA批准进入Neo212二期临床试验——首创口服化学共轭化疗药物用于脑癌治疗
Texpower任命Bader Almonawer为总裁 引领美国锂离子电池制造业未来发展
美股速递 · 2025-09-04
Texpower任命Bader Almonawer为总裁 引领美国锂离子电池制造业未来发展
暂无数据
公司概况
公司名称:
NeOnc Technologies Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
Neonc Technologies Holdings, Inc.于2023年1月5日注册成立,为特拉华州公司。作为一家临床阶段的生物制药公司,该公司一直专注于建立颅内恶性肿瘤的治疗方法,即位于大脑的侵袭性癌症。这些癌症类型包括原发性脑癌,如胶质母细胞瘤,和继发性脑癌,它们是通过全身其他癌症的转移扩散而来的,如黑色素瘤或乳腺癌和肺癌。大脑局限性恶性肿瘤特别难以治疗,因为血脑屏障阻止了大多数药物治疗剂有效进入大脑。因此,这些患者面临着预后不良和平均预期寿命缩短的问题。NeOnc正在开发新的药物递送方法,用于与新的候选药物联合使用。
发行价格:
--
{"stockData":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":10.24,"timestamp":1771016400000,"preClose":10.465,"halted":0,"volume":43859,"hourTrading":{"tag":"盘后","latestPrice":10.24,"preClose":10.24,"latestTime":"16:00 EST","volume":388,"amount":3973.12,"timestamp":1771016402432,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021500238891543205,"floatShares":8266400,"shares":22692159,"eps":-2.5859,"marketStatus":"休市中","change":-0.225,"latestTime":"02-13 16:00:00 EST","open":10.32,"high":10.4871,"low":10.03,"amount":453471.183264,"amplitude":0.043679,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.5859,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":10.465,"preHourTrading":{"tag":"盘前","latestPrice":10.26,"preClose":10.465,"latestTime":"08:20 EST","volume":1,"amount":10.26,"timestamp":1770988849756,"change":-0.205,"changeRate":-0.019589,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":10.24,"preClose":10.24,"latestTime":"16:00 EST","volume":388,"amount":3973.12,"timestamp":1771016402432,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6401484089922737},"requestUrl":"/m/hq/s/NTHI/tweets","defaultTab":"tweets","newsList":[{"id":"1191348497","title":"Neonc Technologies获Cinctive Capital Management领投1000万美元战略PIPE投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1191348497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191348497?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:01","pubTimestamp":1769781715,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings成功获得由Cinctive Capital Management主导的战略性PIPE(私募股权投资公开股)融资,其中Cinctive Capital Management单独注资1000万美元。此次投资将强化Neonc Technologies在医疗科技领域的研发能力与市场扩张步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1162930745","title":"NeOnc Technologies Holdings:向市场提交出售最多111,732股普通股的招股说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1162930745","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162930745?lang=zh_cn&edition=full","pubTime":"2025-12-24 06:10","pubTimestamp":1766527827,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings:向市场提交出售最多111,732股普通股的招股说明书","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1174332497","title":"NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性","url":"https://stock-news.laohu8.com/highlight/detail?id=1174332497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174332497?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:10","pubTimestamp":1762953033,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1132787745","title":"NeOnc Technologies Holdings 达到44%的六个月无进展生存率,超越基准","url":"https://stock-news.laohu8.com/highlight/detail?id=1132787745","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132787745?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:10","pubTimestamp":1762953014,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings 达到44%的六个月无进展生存率,超越基准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1110626785","title":"Neonc Technologies任命Amir Heshmatpour为首席执行官,以推动临床和企业增长的下一个阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1110626785","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110626785?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:02","pubTimestamp":1762264952,"startTime":"0","endTime":"0","summary":"Neonc Technologies任命Amir Heshmatpour为首席执行官,以推动临床和企业增长的下一个阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1173476652","title":"NeOnc Technologies Holdings子公司Nuromena与M42旗下Iros签署主服务协议并扩充董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1173476652","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173476652?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:01","pubTimestamp":1760014893,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings旗下子公司Nuromena日前与M42公司的Iros部门签署了主服务协议,同时宣布扩充其董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1141015679","title":"NeOnc Technologies Holdings任命杜克大学Preston Robert Tisch脑肿瘤中心主任David M. Ashley博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1141015679","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141015679?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:02","pubTimestamp":1759410144,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings宣布任命David M. Ashley博士加入其科学顾问委员会,Ashley博士现任杜克大学Preston Robert Tisch脑肿瘤中心主任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1170203781","title":"NeOnc Technologies欢迎NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任Alexandra M. Miller博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1170203781","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170203781?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:04","pubTimestamp":1759323845,"startTime":"0","endTime":"0","summary":"NeOnc Technologies宣布欢迎Alexandra M. Miller博士加入其科学顾问委员会。Miller博士现任NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1161308975","title":"NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1161308975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161308975?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:01","pubTimestamp":1759150873,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"2566295556","title":"Neonc Technologies Holdings, Inc.盘中异动 股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566295556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566295556?lang=zh_cn&edition=full","pubTime":"2025-09-10 22:42","pubTimestamp":1757515353,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日22时42分,Neonc Technologies Holdings, Inc.股票出现波动,股价快速上涨6.13%。Neonc Technologies Holdings, Inc.股票所在的生物技术行业中,整体涨幅为1.46%。其相关个股中,Galecto, Inc.、Camp4 Therapeutics Corporation、Cdt Equity Inc C/Wts 22/09/2028涨幅较大,Revelation Biosciences, Inc.、Cdt Equity Inc.、Camp4 Therapeutics Corporation较为活跃,换手率分别为700.47%、198.40%、165.33%,振幅较大的相关个股有Camp4 Therapeutics Corporation、Galecto, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ,振幅分别为59.30%、47.67%、37.30%。Neonc Technologies Holdings, Inc.公司简介:NeOnc Technologies Holdings Inc. 是一种新型分子技术的开发商,提供增强靶向技术来治疗中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091022423397862163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091022423397862163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLTO","BK4139","NTHI","BK4007"],"gpt_icon":0},{"id":"1129847890","title":"NeOnc Technologies获得FDA批准进入Neo212二期临床试验——首创口服化学共轭化疗药物用于脑癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1129847890","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129847890?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:01","pubTimestamp":1757509277,"startTime":"0","endTime":"0","summary":"NeOnc Technologies获得美国食品药品监督管理局(FDA)授权,将推进Neo212的二期临床试验。Neo212是一款首创的口服化学共轭化疗候选药物,专门用于脑癌治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1195822031","title":"Texpower任命Bader Almonawer为总裁 引领美国锂离子电池制造业未来发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1195822031","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195822031?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:01","pubTimestamp":1756990876,"startTime":"0","endTime":"0","summary":"Texpower任命Bader Almonawer为总裁,以引领美国锂离子电池制造业迈向未来。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neonctech.com","stockEarnings":[{"period":"1week","weight":0.0481},{"period":"1month","weight":0.0964},{"period":"3month","weight":0.1278},{"period":"6month","weight":1},{"period":"1year","weight":-0.5904},{"period":"ytd","weight":0.2382}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neonc Technologies Holdings, Inc.于2023年1月5日注册成立,为特拉华州公司。作为一家临床阶段的生物制药公司,该公司一直专注于建立颅内恶性肿瘤的治疗方法,即位于大脑的侵袭性癌症。这些癌症类型包括原发性脑癌,如胶质母细胞瘤,和继发性脑癌,它们是通过全身其他癌症的转移扩散而来的,如黑色素瘤或乳腺癌和肺癌。大脑局限性恶性肿瘤特别难以治疗,因为血脑屏障阻止了大多数药物治疗剂有效进入大脑。因此,这些患者面临着预后不良和平均预期寿命缩短的问题。NeOnc正在开发新的药物递送方法,用于与新的候选药物联合使用。","exchange":"NASDAQ","name":"NeOnc Technologies Holdings","nameEN":"NeOnc Technologies Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeOnc Technologies Holdings(NTHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeOnc Technologies Holdings(NTHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeOnc Technologies Holdings,NTHI,NeOnc Technologies Holdings股票,NeOnc Technologies Holdings股票老虎,NeOnc Technologies Holdings股票老虎国际,NeOnc Technologies Holdings行情,NeOnc Technologies Holdings股票行情,NeOnc Technologies Holdings股价,NeOnc Technologies Holdings股市,NeOnc Technologies Holdings股票价格,NeOnc Technologies Holdings股票交易,NeOnc Technologies Holdings股票购买,NeOnc Technologies Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeOnc Technologies Holdings(NTHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeOnc Technologies Holdings(NTHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}